Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use VIMPAT® safely and effectively. See full prescribing information for VIMPAT. VIMPAT® (lacosamide) Tablet, Film Coated for Oral use, CV VIMPAT® (lacosamide) Injection for Intravenous use, CV VIMPAT® (lacosamide) Oral Solution, CVInitial U.S. Approval: 2008
Medication labelWhy this: Advisory · dailymed-prescription
VIMPAT (lacosamide) tablets and oral solution are indicated as adjunctive therapy in the treatment of partial-onset seizures in patients with epilepsy aged 17 years and older. VIMPAT (lacosamide) injection for intravenous use is indicated as adjunctive therapy in the treatment of partial-onset seizures in patients with epilepsy aged 17 years and older when oral administration is temporarily not feasible.
- generic_name
- lacosamide
- product_names
- lacosamide
- ndc
- 54868-6077, 0131-2477, 54868-6077-0
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en